Ischemia-induced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14)

American Journal of Physiology - Renal Physiology

Volumn 290, Issue 1, 2006, Pages

  Covington, Marisa D ^a   Burghardt, Robert C ^b   Parrish, Alan R ^a,c  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c Reynolds Medical Bldg   (United States)

Author keywords

Acute renal failure; Proximal tubules; shRNA

Indexed keywords

CADHERIN; CATENIN; FIBRONECTIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; NERVE CELL ADHESION MOLECULE; NEUTRALIZING ANTIBODY; PROTEINASE INHIBITOR; SHORT HAIRPIN RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; MMP14 PROTEIN, MOUSE;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; ISCHEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; CELL LINE; GENETIC TRANSFECTION; KIDNEY CIRCULATION; KIDNEY PROXIMAL TUBULE; L CELL; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

ANIMALS; BASE SEQUENCE; CADHERINS; CELL LINE; EXTRACELLULAR MATRIX; ISCHEMIA; KIDNEY TUBULES, PROXIMAL; L CELLS (CELL LINE); MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; MICE; MOLECULAR SEQUENCE DATA; PROTEASE INHIBITORS; RATS; RENAL CIRCULATION; TRANSFECTION;

EID: 33644800143     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00179.2005     Document Type: Article

References (57)

1. Ara T, Deyama Y, Yoshimura Y, Higashino F, Shindoh M, Matsumoto A, and Fukuda H. Membrane type 1-matrix metalloproteinase expression is regulated by E-cadherin through the suppression of mitogen-activated protein kinase cascade. Cancer Lett 157: 115-121, 2000.
2. Basile DP, Fredrich K, Weihrauch D, Hattan N, and Chilian WM. Angiostatin and matrix metalloprotease expression following ischemic acute renal failure. Am J Physiol Renal Physiol 286: F893-F902, 2004.
3. Bonventre JV and Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14: 2199-2210, 2003.
4. Bush KT, Tsukamoto T, and Nigam SK. Selective degradation of E-cadherin and dissolution of E-cadherin-catenin complexes in epithelial ischemia. Am J Physiol Renal Physiol 278: F847-F852, 2000.
5. Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, van Westrum SS, Crabbe T, Clements J, d'Ortho MP, and Murphy G. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem 273: 871-880, 1998.
6. Chung SS, Mo MY, Silvestrini B, Lee WM, and Cheng CY. Rat testicular N-cadherin: its complementary deoxyribonucleic acid cloning and regulation. Endocrinology 139: 1853-1862, 1998.
7. Covington MD, Bayless KJ, Burghardt RC, Davis GE, and Parrish AR. Ischemia-induced cleavage of cadherins in NRK cells: evidence for a role of metalloproteinases. Am J Physiol Renal Physiol 289: F280-F288, 2005.
8. v subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. J Biol Chem 277: 9749-9756, 2002.
9. Deschamps AM, Yarbrough WM, Squires CE, Allen RA, McClister DM, Dowdy KB, McLean JE, Mingoia JT, Sample JA, Mukherjee R, and Spinale FG. Trafficking of the membrane type-1 matrix metalloproteinase in ischemia and reperfusion: relation to interstitial membrane type-1 matrix metalloproteinase activity. Circulation 111: 1166-1174, 2005.
10. D'Ortho MP, Stanton H, Butler M, Atkinson SJ, Murphy G, and Hembry RM. MT1-MMP on the cell surface causes focal degradation of gelatin films. FEBS Lett 421: 159-164, 1998.
11. Fujimori T and Takeichi M. Disruption of epithelial cell-cell adhesion by exogenous expression of a mutated nonfunctional N-cadherin. Mol Biol Cell 4: 37-47, 1993.
12. 3 integrins at distinct cell compartments modulating its internalization and activity on human endothelial cells. J Cell Biol 159: 509-521, 2002.
13. Hernandez-Barrantes S, Bernardo M, Toth M, and Fridman R. Regulation of membrane type-matrix metalloproteinases. Semin Cancer Biol 12: 131-138, 2002.
14. Herren B, Levkau B, Raines EW, and Ross R. Cleavage of β-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role of caspases and metalloproteinases. Mol Biol Cell 9: 1589-1601, 1998.
15. Ito K, Okamoto I, Araki N, Kawano Y, Nakao M, Fujiyama S, Tomita K, Mimori T, and Saya H. Calcium influx triggers the sequential proteolysis of extracellular and cytoplasmic domains of E-cadherin, leading to loss of β-catenin from cell-cell contacts. Oncogene 18: 7080-7090, 1999.
16. 2-induced nephrotoxicity. Toxicol Sci 80: 170-182, 2004.
17. Jung KY, Dean D, Jiang J, Gaylor S, Griffith WH, Burghardt RC, and Parrish AR. Loss of N-cadherin and alpha-catenin in the proximal tubules of aging male Fischer 344 rats. Mech Ageing Dev 125: 445-453, 2004.
18. Kitagawa Y, Kunimi K, Uchibayashi T, Sato H, and Namiki M. Expression of messenger RNAs for membrane-type 1, 2, and 3 matrix metalloproteinases in human renal cell carcinoma. J Urol 162: 905-909, 1999.
19. Knauper V, Will H, Lopez-Otin C, Smith B, Atkinson SJ, Stanton H, Hembry RM, and Murphy G. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J Biol Chem 271: 17124-17131, 1996.
20. Kohya N, Kitajima Y, Jiao W, and Miyazaki K. Effects of E-cadherin transfection on gene expression of a gallbladder carcinoma cell line: repression of MTS1/S100A4 gene expression. Int J Cancer 104: 44-53, 2003.
21. Kwon O, Nelson WJ, Sibley R, Huie P, Scandling JD, Dafoe D, Alfrey E, and Myers BD. Backleak, tight junctions, and cell-cell adhesion in postischemic injury to the renal allograft. J Clin Invest 101: 2054-2064, 1998.
22. Laplante A, Liu D, Demeule M, Annabi B, Murphy GF, Daloze P, Chen H, and Beliveau R. Modulation of matrix gelatinases and metalloproteinase-activating process in acute kidney rejection. Transpl Int 16: 262-269, 2003.
23. Llano E, Pendas AM, Freije JP, Nakano A, Knauper V, Murphy G, and Lopez-Otin C. Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase A overexpressed in brain tumors. Cancer Res 59: 2570-2576, 1999.
24. Lochter A, Galosy S, Muschler J, Freedman N, Werb Z, and Bissell MJ. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol 139: 1861-1872, 1997.
25. +-ATPase and E-cadherin. J Cell Sci 107: 3315-3324, 1994.
26. Marambaud P, Shioi J, Serban G, Georgakopoulos A, Sarner S, Nagy V, Baki L, Wen P, Efthimiopoulos S, Shao Z, Wisniewski T, and Robakis NK. A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J 21: 1948-1956, 2002.
27. McGuire JK, Li Q, and Parks WC. Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. Am J Pathol 162: 1831-1843, 2003.
28. Meldrum KK, Meldrum DR, Hile KL, Burnett AL, and Harken AH. A novel model of ischemia in renal tubular cells which closely parallels in vivo injury. J Surg Res 99: 288-293, 2001.
29. Molitoris BA and Marrs J. The role of cell adhesion molecules in ischemic acute renal failure. Am J Med 106: 583-592, 1999.
30. Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D'Agati V, Devarajan P, and Barasch J. Endocytic delivery of lipocalin-sideophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 115: 610-621, 2005.
31. Muhs BE, Plitas G, Delgado Y, Ianus I, Shaw JP, Adelman MA, Lamparello P, Shamamian P, and Gagne P. Temporal expression and activation of matrix metalloproteinases-2, -9, and membrane type 1-matrix metalloproteinase following acute hindlimb ischemia. J Surg Res 111: 8-15, 2003.
32. Murphy F, Waung J, Collins J, Arthur MJ, Nagase H, Mann D, Benyon RC, and Iredale JP. N-Cadherin cleavage during activated hepatic stellate cell apoptosis is inhibited by tissue inhibitor of metalloproteinase-1. Comp Hepatol 3: S8, 2004.
33. Murphy GJ, Murphy G, and Reynolds JJ. The origin of matrix metalloproteinases and their familial relationships. FEBS Lett 289: 4-7, 1991.
34. Nagase H and Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 274: 21491-21494, 1999.
35. Nawrocki-Raby B, Gilles C, Polette M, Bruyneel E, Laronze JY, Bonnet N, Foidart JM, Mareel M, and Birembaut P. Upregulation of MMPs by soluble E-cadherin in human lung tumor cells. Int J Cancer 105: 790-795, 2003.
36. Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel E, Matrisian LM, and Mareel M. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 114: 111-118, 2001.
37. Obermuller N, Morente N, Kranzlin B, Gretz N, and Witzgall R. A possible role for metalloproteinases in renal cyst development. Am J Physiol Renal Physiol 280: F540-F550, 2001.
38. Paddison PJ, Caudy JA, Bernstein E, Hannon GJ, and Conklin DS. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 16: 948-958, 2002.
39. Perl A, Wilgenbus P, Dahl U, Semb H, and Christofori G. MMP3 cleaves E-cadherin. Nature 392: 190-193, 1998.
40. Pon YL, Auersperg N, and Wong AST. Gonadotropins regulate N-cadherin-mediated human ovarian surface epithelial cell survival at both posttranslational and transcriptional levels through a cyclic AMP/protein kinase A pathway. J Biol Chem 280: 15438-15448, 2005.
41. Reiss K, Maretzky T, Ludwig A, Tousseyn T, de Strooper B, Hartmann D, and Saftig P. ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and β-catenin nuclear signalling. EMBO J 24: 742-752, 2005.
42. Rozanov DV, Deryugina Monosov EZ, Marchenko ND, and Strongin AY. Aberrant, persistent inclusion into lipid rafts limits the tumorigenic function of membrane type-1 matrix metalloproteinase in malignant cells. Exp Cell Res 293: 81-95, 2004.
43. Sato H, Kinoshita T, Takino T, Nakayama K, and Seiki M. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 393: 101-104, 1996.
44. Schulze CJ, Wang W, Suarez-Pinzon WL, Sawicka J, Sawicki G, and Schulz R. Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial ischemia-reperfusion injury. Circulation 107: 2487-2492, 2003.
45. Selvey S, Haupt LM, Thompson EW, Matthaei KI, Irving MG, and Griffiths LR. Stimulation of MMP-11 (stromelysin-3) expression in mouse fibroblasts by cytokines, collagen and co-culture with human breast cancer cell lines. BMC Cancer 4: 40, 2004.
46. Singri N, Ahya SN, and Levin ML. Acute renal failure. JAMA 289: 747-751, 2003.
47. Sole S, Petegnief V, Gorina R, Chamorro A, and Planas AM. Activation of matrix metalloproteinase-3 and agrin cleavage in cerebral ischemia/reperfusion. J Neuropathol Exp Neurol 63: 338-349, 2004.
48. Steinhusen U, Weiske J, Badock V, Tauber R, Bommert K, and Huber O. Cleavage and shedding of E-cadherin after induction of apoptosis. J Biol Chem 276: 4972-4980, 2001.
49. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, and Goldberg GI. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270: 5331-5338, 1995.
50. Surendran K, Simon TC, Liapis H, and McGuire JK. Matrilysin (MMP-7) expression in renal tubular damage: association with Wnt4. Kidney Int 65: 2212-2222, 2004.
51. Suzuki K, Nakayama H, and Doi K. Kinetics of matrix metalloproteinases and their regulatory factors in mercuric chloride-induced tubulointerstitial fibrosis in Brown Norway rats. Exp Toxicol Pathol 53: 337-343, 2001.
52. Toth M, Chvyrkova I, Bernardo MM, Hernandez-Barrantes S, and Fridman R. Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes. Biochem Biophys Res Commun 308: 386-395, 2003.
53. Uglow EB, Slater S, Sala-Newby GB, Aguilera-Garcia CM, Angelini GD, Newby AC, and George SJ. Dismantling of cadherin-mediated cell-cell contacts modulates smooth muscle cell proliferation. Circ Res 92: 1314-1321, 2003.
54. Wada K, Sato H, Kinoh H, Kajita M, Yamamoto H, and Seiki M. Cloning of three Caenorhabditis elegans genes potentially encoding novel matrix metalloproteinases. Gene 211: 57-62, 1998.
55. Wu WB and Huang TF. Activation of MMP-2, cleavage of matrix proteins, and adherens junctions during a snake venom metalloproteinase-induced endothelial cell apoptosis. Exp Cell Res 288: 143-157, 2003.
56. Yano M, Omoto Y, Yamakawa Y, Nakashima Y, Kiriyama M, Saito Y, and Fujii Y. Increased matrix metalloproteinase 9 activity and mRNA expression in lung ischemia-reperfusion injury. J Heart Lung Transplant 20: 679-686, 2001.
57. Ziswiler R, Daniel C, Franz E, and Marti HP. Renal matrix metalloproteinase activity is unaffected by experimental ischemia-reperfusion injury and matrix metalloproteinase inhibition does not alter outcome of renal function. Exp Nephrol 9: 118-124, 2001.